AQST
Aquestive Therapeutics Inc
NASDAQ: AQST · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$4.10
+1.23% today
Updated 2026-04-30
Market cap
$509.57M
P/E ratio
—
P/S ratio
11.44x
EPS (TTM)
$-0.78
Dividend yield
—
52W range
$2 – $8
Volume
1.7M
Aquestive Therapeutics Inc (AQST) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |